Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts.
Open Access
- 1 October 1997
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 100 (7), 1742-1749
- https://doi.org/10.1172/jci119699
Abstract
We asked whether thyroid hormone (T4) would improve heart function in left ventricular hypertrophy (LVH) induced by pressure overload (aortic banding). After banding for 10-22 wk, rats were treated with T4 or saline for 10-14 d. Isovolumic LV pressure and cytosolic [Ca2+] (indo-1) were assessed in perfused hearts. Sarcoplasmic reticulum Ca2+-ATPase (SERCA), phospholamban, and alpha- and beta-myosin heavy chain (MHC) proteins were assayed in homogenates of myocytes isolated from the same hearts. Of 14 banded hearts treated with saline, 8 had compensated LVH with normal function (LVHcomp), whereas 6 had abnormal contraction, relaxation, and calcium handling (LVHdecomp). In contrast, banded animals treated with T4 had no myocardial dysfunction; these hearts had increased contractility, and faster relaxation and cytosolic [Ca2+] decline compared with LVHcomp and LVHdecomp. Myocytes from banded hearts treated with T4 were hypertrophied but had increased concentrations of alpha-MHC and SERCA proteins, similar to physiological hypertrophy induced by exercise. Thus thyroid hormone improves LV function and calcium handling in pressure overload hypertrophy, and these beneficial effects are related to changes in myocyte gene expression. Induction of physiological hypertrophy by thyroid hormone-like signaling might be a therapeutic strategy for treating cardiac dysfunction in pathological hypertrophy and heart failure.This publication has 47 references indexed in Scilit:
- Cytosolic and mitochondrial [Ca2+] in whole hearts using indo-1 acetoxymethyl ester: effects of high extracellular Ca2+Biophysical Journal, 1996
- Thyroid hormone therapy in cardiovascular diseaseProgress in Cardiovascular Diseases, 1996
- Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure.Journal of Clinical Investigation, 1995
- Ca2+ transient decline and myocardial relaxation are slowed during low flow ischemia in rat hearts.Journal of Clinical Investigation, 1994
- Cardiac contractile dysfunction during mild coronary flow reductions is due to an altered calcium-pressure relationship in rat hearts.Journal of Clinical Investigation, 1992
- Thyroid hormone regulation of alpha-myosin heavy chain promoter activity assessed by invivo DNA transfer in rat heartBiochemical and Biophysical Research Communications, 1991
- Cytoplasmic [Ca2+] in Mammalian Ventricle: Dynamic Control by Cellular ProcessesAnnual Review of Physiology, 1990
- Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals.Journal of Clinical Investigation, 1987
- Regional differences in myocyte size in normal rat heartThe Anatomical Record, 1986
- Cardiac conditioning ameliorates cardiac dysfunction associated with renal hypertension in rats.Journal of Clinical Investigation, 1984